Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05429762
Title Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors (TusaRav-QT)
Acronym TusaRav-QT
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | BEL

No variant requirements are available.